NDA 208805 describes ETHACRYNIC ACID, which is a drug marketed by
Adaptis,
Agnitio,
Alvogen,
Amneal Pharms Co,
Chartwell Rx,
Endo Operations,
Hikma,
Lupin Ltd,
Sciegen Pharms Inc, and
Upsher Smith Labs, and is included in ten NDAs. It is available from
eight suppliers. Additional details are available on the
ETHACRYNIC ACID profile page.
The generic ingredient in ETHACRYNIC ACID is
ethacrynic acid. There are thirteen
drug master file entries for this compound. Ten
suppliers are listed for this compound. Additional details are available on the
ethacrynic acid profile page.